Belfast · Northern Ireland
TheBELFAST HERALDLocal knowledge. National perspective.
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works
HealthPremium archive

Therapeutic Goods Administration approves the usage of the Pfizer-BioNTech COVID-19 vaccine as a booster dose for people over the age of 18 years old,

The Therapeutic Goods Administration approves the usage of the Pfizer-BioNTech COVID-19 vaccine as a booster dose for people over the age of 18 years old, which can be administered at least six months after the second dose.

By Belfast Herald Newsdesk1 min read

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthTherapeutic Goods Administration approves the usage of the Pfizer-BioNTech COVID-19 vaccine as a booster dose for people over the age of 18 years old,

The Therapeutic Goods Administration approves the usage of the Pfizer-BioNTech COVID-19 vaccine as a booster dose for people over the age of 18 years old, which can be administered at least six months after the second dose.

View Premium plansBrowse free archive reports